Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Therapy in Patients With Autism
NCT01343511Phase 2Completed
- Sponsor
- Beike Biotechnology
- Start
- Mar 2009
- Primary completion
- Jun 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood mononuclear cells, human umbilical cord mesenchymal stem cells in Autism Spectrum Disorder (ASD), sponsored by Beike Biotechnology. Started Mar 2009; status: completed.
02
Drugs
umbilical cord blood mononuclear cellshuman umbilical cord mesenchymal stem cells
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01343511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01343511.